Skip to main content
. 2017 Jan 3;16:8. doi: 10.1186/s12936-016-1655-1

Table 2.

Overview of adverse events

Number of adverse events Number of episodes Incidence
Any adverse event 2545 1978 13.0% [12.5%; 13.6%]
Serious adverse events 105 100 0.7% [0.5%; 0.8%]
Severe adverse events 154 126 0.8% [0.7%; 1.0%]
Adverse events of special interest 3 3 <0.1%
Fatal serious adverse events 24 22 0.2% [0.1%; 0.2%]
Potentially ASAQ-related adverse events 929 837 5.5% [5.2%; 5.9%]
Adverse events requiring corrective treatment 157 105 0.7% [0.6%; 0.8%]